Long-term Virological Outcomes of First-Line Antiretroviral Therapy for HIV-1 in Low- and Middle-Income Countries: A Systematic Review and Meta-analysis.
about
Long-Term Antiretroviral Treatment Adherence in HIV-Infected Adolescents and Adults in Uganda: A Qualitative StudyAssessment of the World Health Organization's HIV Drug Resistance Early Warning Indicators in Main and Decentralized Outreach Antiretroviral Therapy Sites in NamibiaLong-Term Outcomes on Antiretroviral Therapy in a Large Scale-Up Program in Nigeria.Global epidemiology of drug resistance after failure of WHO recommended first-line regimens for adult HIV-1 infection: a multicentre retrospective cohort studyVirological success after 12 and 24 months of antiretroviral therapy in sub-Saharan Africa: Comparing results of trials, cohorts and cross-sectional studies using a systematic review and meta-analysis.Occult HIV-1 drug resistance to thymidine analogues following failure of first-line tenofovir combined with a cytosine analogue and nevirapine or efavirenz in sub Saharan Africa: a retrospective multi-centre cohort study.Virological Outcomes of Second-line Protease Inhibitor-Based Treatment for Human Immunodeficiency Virus Type 1 in a High-Prevalence Rural South African Setting: A Competing-Risks Prospective Cohort Analysis.High rate of virological failure and low rate of switching to second-line treatment among adolescents and adults living with HIV on first-line ART in Myanmar, 2005-2015The virological durability of first-line ART among HIV-positive adult patients in resource limited settings without virological monitoring: a retrospective analysis of DART trial data.Low-Frequency Drug Resistance in HIV-Infected Ugandans on Antiretroviral Treatment Is Associated with Regimen Failure.Minimizing fungal disease deaths will allow the UNAIDS target of reducing annual AIDS deaths below 500 000 by 2020 to be realizedWide variation in susceptibility of transmitted/founder HIV-1 subtype C Isolates to protease inhibitors and association with in vitro replication efficiency.Beyond the 90-90-90: refocusing HIV prevention as part of the global HIV response.Mechanisms of Accelerated Liver Fibrosis Progression during HIV Infection.Can the UNAIDS 90-90-90 target be achieved? A systematic analysis of national HIV treatment cascades.Durability of viral suppression with first-line antiretroviral therapy in patients with HIV in the UK: an observational cohort study.Effect of frequency of clinic visits and medication pick-up on antiretroviral treatment outcomes: a systematic literature review and meta-analysis.Association Between Food Insecurity and HIV Viral Suppression: A Systematic Review and Meta-Analysis.Accumulation of HIV-1 drug resistance after continued virological failure on first-line ART in adults and children in sub-Saharan Africa.Pretreatment HIV drug resistance increases regimen switches in sub-Saharan Africa.Suboptimal Viral Suppression Rates Among HIV-Infected Children in Low- and Middle-Income Countries: A Meta-analysis.Rates of virological suppression and drug resistance in adult HIV-1-positive patients attending primary healthcare facilities in KwaZulu-Natal, South Africa.Multicentre analysis of second-line antiretroviral treatment in HIV-infected children: adolescents at high risk of failure.Editorial Commentary: Scaling Up Antiretroviral Therapy in Africa: Are We There Yet?Long-term Outcome of Antiretroviral Treatment in Patients With and Without Concomitant Tuberculosis Receiving Health Center-Based Care-Results From a Prospective Cohort Study.Human Immunodeficiency Virus Resistance Testing Technologies and Their Applicability in Resource-Limited Settings of Africa.Immuno-virological response and associated factors amongst HIV-1 vertically infected adolescents in Yaoundé-Cameroon.Effectiveness of Protease Inhibitor/Nucleos(t)ide Reverse Transcriptase Inhibitor-Based Second-line Antiretroviral Therapy for the Treatment of Human Immunodeficiency Virus Type 1 Infection in Sub-Saharan Africa: A Systematic Review and Meta-analysiHIV-1 drug resistance before initiation or re-initiation of first-line antiretroviral therapy in low-income and middle-income countries: a systematic review and meta-regression analysis.Routine viral load monitoring in HIV-infected infants and children in low- and middle-income countries: challenges and opportunities.Long-term clinical, immunological and virological outcomes of patients on antiretroviral therapy in southern Myanmar.Optimal timing of HIV home-based counselling and testing rounds in Western Kenya.Adherence to Nucleos(t)ide Analogue Therapies for Chronic Hepatitis B Infection: A Systematic Review and Meta-AnalysisDrug resistance outcomes of long-term ART with tenofovir disoproxil fumarate in the absence of virological monitoring
P2860
Q28554577-A88F012D-BBBC-48B4-B24C-F07068B818E0Q28554721-8625F460-EA27-4566-8C59-7ADD619BD879Q30380873-9FE9E139-FFA4-4CE9-9144-0C8E344BC513Q30384060-20722949-066C-4594-BDB5-A028CACC7120Q33584656-6FBF343A-F846-492D-ADE3-9F04B3715245Q33647567-91705655-EC53-4644-8629-CC790D620F13Q33712438-2CBCA8CF-CD37-4BC3-8AAB-1E3EFC01E591Q36275812-86FE21BB-D9C3-4EAB-99FE-CDF57DD83C6DQ36286733-376DB5C5-55D1-4D2B-A037-F327ACC58FA2Q36933330-F394E615-694B-461A-8379-8913AB99B695Q37393668-6474BEFE-6F18-4F89-9B70-8580B099CEF8Q37454209-23CD72D7-043A-4371-B58C-C2DED4ACF5ADQ37512411-B9214E29-DBE3-4638-8935-8E5F054AC771Q37578291-5931596D-F0CA-4611-957E-A7A804E66E87Q37659717-B49714DE-38B0-42EB-956F-BB4326309B82Q38401143-6724BC12-1FA9-48A1-B7CA-31C1234DAEABQ38645060-056EB47E-5271-4A67-99AD-184BC65D4EC8Q38852232-7C7A863D-7DC0-4DA2-AA3A-481D073A80BBQ38854117-97AB8C2D-A159-4668-9064-53B063E25BD1Q38858252-D11222F9-A229-45ED-A026-E636AA9A68D4Q38913065-71B92FE2-08D8-405F-B3AE-5A60CA380D36Q41923640-E3FA4A37-E99F-494F-87B0-3B0DD91C30E0Q41929466-8C5C0FF0-A839-4083-9CED-32CCC75ACDD5Q44739822-E693574D-4993-4A21-9325-1883184F3FABQ46634665-3342E691-6AAD-4C83-AE3D-601451DF0F18Q47113253-3BA9D98B-55CE-4AA0-BCFF-D51E21FFC3A5Q47149048-68A1658E-7E43-4E5D-A2DC-44AF6DC2742BQ47258937-79A271FB-061B-4810-A9FB-30EEBE7EAA5AQ47378001-29247B63-CC39-4CB6-A2EE-E89986EB9C48Q47420316-6AF40D7B-C61E-443C-BF3A-4A87358337DCQ50053558-8778F764-B344-4B82-8CCF-449E9AD81327Q55362954-A64A011A-56D9-4158-A51D-6E0AD3ABC710Q57069784-A3C42F87-6F45-4A0A-879D-CC061B0E960CQ57500517-A5FC2EA9-D169-4DDF-A1D5-132F725F6CF0
P2860
Long-term Virological Outcomes of First-Line Antiretroviral Therapy for HIV-1 in Low- and Middle-Income Countries: A Systematic Review and Meta-analysis.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Long-term Virological Outcomes ...... atic Review and Meta-analysis.
@ast
Long-term Virological Outcomes ...... atic Review and Meta-analysis.
@en
type
label
Long-term Virological Outcomes ...... atic Review and Meta-analysis.
@ast
Long-term Virological Outcomes ...... atic Review and Meta-analysis.
@en
prefLabel
Long-term Virological Outcomes ...... atic Review and Meta-analysis.
@ast
Long-term Virological Outcomes ...... atic Review and Meta-analysis.
@en
P2093
P2860
P356
P1476
Long-term Virological Outcomes ...... atic Review and Meta-analysis.
@en
P2093
Jhoney Barcarolo
Kim C E Sigaloff
Michael R Jordan
Nathan Ford
Sasisopin Kiertiburanakul
Silvia Bertagnolio
Tobias F Rinke de Wit
P2860
P304
P356
10.1093/CID/CIV556
P407
P577
2015-07-08T00:00:00Z